Jim Simons Galera Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.09 - $0.27 $28,215 - $84,645	313,500 New	313,500 $46,000
Q2 2023 Aug 11, 2023	BUY	$2.5 - $3.42 $36,000 - $49,248	14,400 Added 7.08%	217,900 $680,000
Q1 2023 May 12, 2023	BUY	$1.48 - $2.68 $238,280 - $431,480	161,000 Added 378.82%	203,500 $521,000
Q4 2022 Feb 13, 2023	SELL	$1.34 - $1.78 $154,459 - $205,177	-115,268 Reduced 73.06%	42,500 $63,000
Q3 2022 Nov 14, 2022	SELL	$1.15 - $2.1 $97,271 - $177,626	-84,584 Reduced 34.9%	157,768 $275,000
Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.39 $244,009 - $470,308	-196,782 Reduced 44.81%	242,352 $315,000
Q1 2022 May 13, 2022	BUY	$2.01 - $4.19 $882,659 - $1.84 Million	439,134 New	439,134 $1.05 Million
Q4 2021 Feb 11, 2022	SELL	$1.27 - $8.28 $30,060 - $195,987	-23,670 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.04 - $10.49 $3,520 - $5,245	-500 Reduced 2.07%	23,670 $192,000
Q2 2021 Aug 13, 2021	SELL	$6.08 - $10.44 $78,498 - $134,790	-12,911 Reduced 34.82%	24,170 $238,000
Q1 2021 May 13, 2021	BUY	$8.35 - $12.39 $136,196 - $202,093	16,311 Added 78.53%	37,081 $327,000
Q4 2020 Feb 10, 2021	BUY	$8.02 - $12.81 $61,754 - $98,637	7,700 Added 58.91%	20,770 $212,000
Q3 2020 Nov 13, 2020	SELL	$6.96 - $9.12 $62,591 - $82,016	-8,993 Reduced 40.76%	13,070 $118,000
Q2 2020 Aug 13, 2020	BUY	$7.14 - $14.41 $157,529 - $317,927	22,063 New	22,063 $158,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.